Header Logo

Katherine Ruiz De Luzuriaga MD

TitleProfessor
Endowed TitleUMass Memorial Health Care Chair in Biomedical Research
InstitutionUMass Chan Medical School
DepartmentProgram in Molecular Medicine
AddressUMass Chan Medical School
373 Plantation Street Two Biotech Suite 318
Worcester MA 01605
Phone774-455-4770
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine
    DivisionInfectious Diseases

    InstitutionT.H. Chan School of Medicine
    DepartmentPediatrics

    InstitutionT.H. Chan School of Medicine
    DepartmentProgram in Molecular Medicine

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentImmunology and Microbiology Program

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentInterdisciplinary Graduate Program

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentMasters in Clinical Investigation

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentMD/PhD Program

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentPopulation Health Sciences

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentPostbaccalaureate Research Education Program

    InstitutionMorningside Graduate School of Biomedical Sciences
    DepartmentTranslational Science

    InstitutionUMass Chan Programs, Centers and Institutes
    DepartmentBioinformatics and Integrative Biology


    Collapse Biography 
    Collapse education and training
    Massachusetts Institute of Technology, Cambridge, MA, United StatesBA
    Massachusetts Institute of Technology, Cambridge, MA, United StatesBSApplied Biology
    Massachusetts Institute of Technology, Cambridge, MA, United StatesMA
    Massachusetts Institute of Technology, Cambridge, MA, United StatesMSNutritional Biochemistry
    Tufts University School of Medicine, Boston, MA, United StatesMD

    Collapse Overview 
    Collapse overview

    Academic Background

    S.B., S.M. - Massachusetts Institute of Technology

    M.D. (1984) Tufts University

    Professor,
    Department of Pediatrics and Program in Molecular Medicine

    Virus-Host Dynamics in Persistent Viral Infections

    Dr. Luzuriaga

    Research in my laboratory is focused on the viral and immunopathogenesis of persistent viral infections in humans, including human immunodeficiency virus (HIV), Epstein Barr virus (EBV), and cytomegalovirus (CMV). Ongoing studies are focused on: 1) examining the relationship between viral replication/viral gene expression and the development of the antiviral CD4+ and CD8+ T cell repertoires from acute through chronic infection; 2) characterization of the ontogeny of cell-mediated immune responses to viral infections in infants and children; and 3) the development of prophylactic and therapeutic vaccine strategies for HIV.


    Collapse Rotation Projects

    Potential Rotation Projects:

    Contact Dr. Luzuriaga for project details.



    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rose R, Gonzalez-Perez MP, Nolan D, Ganta KK, LaFleur T, Cross S, Brody R, Lamers SL, Luzuriaga K. Distinct HIV-1 Population Structure across Meningeal and Peripheral T Cells and Macrophage Lineage Cells. Microbiol Spectr. 2022 10 26; 10(5):e0250822. PMID: 36173332.
      Citations:    
    2. Ma KC, Hale JE, Grad YH, Alter G, Luzuriaga K, Eaton RB, Fischinger S, Kaur D, Brody R, Siddiqui SM, Leach D, Brown CM, Klevens RM, Madoff L, Comeau AM. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens. Clin Infect Dis. 2022 08 24; 75(1):e105-e113. PMID: 35213690.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    3. Ruggiero A, Pascucci GR, Cotugno N, Dom?nguez-Rodr?guez S, Rinaldi S, Tagarro A, Rojo P, Foster C, Bamford A, De Rossi A, Nastouli E, Klein N, Morrocchi E, Fatou B, Smolen KK, Ozonoff A, Di Pastena M, Luzuriaga K, Steen H, Giaquinto C, Goulder P, Rossi P, Levy O, Pahwa S, Palma P. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy. Front Immunol. 2022; 13:860418. PMID: 35432380.
      Citations:    
    4. Rose R, Gonzalez-Perez MP, Nolan DJ, Cross S, Lamers SL, Luzuriaga K. Ultradeep HIV-1 Proviral Envelope Sequencing Reveals Complex Population Structure within and between Brain and Splenic Tissues. J Virol. 2021 11 09; 95(23):e0120221. PMID: 34495695.
      Citations:    
    5. Ehrlich R, Kamga L, Gil A, Luzuriaga K, Selin LK, Ghersi D. SwarmTCR: a computational approach to predict the specificity of T cell receptors. BMC Bioinformatics. 2021 Sep 07; 22(1):422. PMID: 34493215.
      Citations: 4     Fields:    
    6. McManus M, Karalius B, Patel K, Persaud D, Luzuriaga K. Quantitative HIV-1-specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations. AIDS. 2020 07 01; 34(8):1117-1126. PMID: 32287055.
      Citations: 2     Fields:    Translation:HumansCells
    7. Palma P, McManus M, Cotugno N, Rocca S, Rossi P, Luzuriaga K. The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV. Lancet HIV. 2020 05; 7(5):e359-e365. PMID: 32386722.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    8. Gil A, Kamga L, Chirravuri-Venkata R, Aslan N, Clark F, Ghersi D, Luzuriaga K, Selin LK. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor a and ? Repertoires. mBio. 2020 03 17; 11(2). PMID: 32184241.
      Citations: 11     Fields:    Translation:HumansCells
    9. Kamga L, Gil A, Song I, Brody R, Ghersi D, Aslan N, Stern LJ, Selin LK, Luzuriaga K. CDR3a?drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection. PLoS Pathog. 2019 11; 15(11):e1008122. PMID: 31765434.
      Citations: 14     Fields:    Translation:HumansCells
    10. McManus M, Henderson J, Gautam A, Brody R, Weiss ER, Persaud D, Mick E, Luzuriaga K. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy. Clin Infect Dis. 2019 05 02; 68(10):1725-1732. PMID: 30668843.
      Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
    11. Brumme ZL, Sudderuddin H, Ziemniak C, Luzuriaga K, Jones BR, Joy JB, Cunningham CK, Greenough T, Persaud D. Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth. AIDS. 2019 02 01; 33(2):211-218. PMID: 30325763.
      Citations: 10     Fields:    Translation:HumansCells
    12. Quitadamo B, Peters PJ, Koch M, Luzuriaga K, Cheng-Mayer C, Clapham PR, Gonzalez-Perez MP. No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications. Arch Virol. 2019 Feb; 164(2):473-482. PMID: 30415390.
      Citations:    Fields:    Translation:HumansCells
    13. Brese RL, Gonzalez-Perez MP, Koch M, O'Connell O, Luzuriaga K, Somasundaran M, Clapham PR, Dollar JJ, Nolan DJ, Rose R, Lamers SL. Ultradeep single-molecule real-time sequencing of HIV envelope reveals complete compartmentalization of highly macrophage-tropic R5 proviral variants in brain and CXCR4-using variants in immune and peripheral tissues. J Neurovirol. 2018 08; 24(4):439-453. PMID: 29687407.
      Citations: 12     Fields:    Translation:HumansCells
    14. Quitadamo B, Peters PJ, Repik A, O'Connell O, Mou Z, Koch M, Somasundaran M, Brody R, Luzuriaga K, Wallace A, Wang S, Lu S, McCauley S, Luban J, Duenas-Decamp M, Gonzalez-Perez MP, Clapham PR. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded. J Virol. 2018 01 15; 92(2). PMID: 29118121.
      Citations: 9     Fields:    Translation:HumansCells
    15. Weiss ER, Lamers SL, Henderson JL, Melnikov A, Somasundaran M, Garber M, Selin L, Nusbaum C, Luzuriaga K. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection. J Virol. 2018 01 15; 92(2). PMID: 29093087.
      Citations: 21     Fields:    Translation:HumansCells
    16. Aslan N, Watkin LB, Gil A, Mishra R, Clark FG, Welsh RM, Ghersi D, Luzuriaga K, Selin LK. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires. mBio. 2017 Dec 05; 8(6). PMID: 29208744.
      Citations: 22     Fields:    Translation:HumansCells
    17. Gonzalez-Perez MP, Peters PJ, O'Connell O, Silva N, Harbison C, Cummings Macri S, Kaliyaperumal S, Luzuriaga K, Clapham PR. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol. 2017 10 15; 91(20). PMID: 28768859.
      Citations: 11     Fields:    Translation:HumansCells
    18. Watkin LB, Mishra R, Gil A, Aslan N, Ghersi D, Luzuriaga K, Selin LK. Unique influenza A?cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol. 2017 10; 140(4):1206-1210. PMID: 28629751.
      Citations: 10     Fields:    Translation:HumansCells
    19. Rainwater-Lovett K, Ziemniak C, Watson D, Luzuriaga K, Siberry G, Petru A, Chen Y, Uprety P, McManus M, Ho YC, Lamers SL, Persaud D. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection. PLoS One. 2017; 12(2):e0170548. PMID: 28178277.
      Citations: 15     Fields:    Translation:HumansCells
    20. Calvin-Naylor NA, Jones CT, Wartak MM, Blackwell K, Davis JM, Divecha R, Ellerbeck EF, Kieburtz K, Koziel MJ, Luzuriaga K, Maddox J, Needler NA, Murphy S, Pemberton K, Radovich C, Rubinstein EP, Selker HP, Tenaerts P, Unsworth K, Wilson K, Wright JE, Barohn R, Shanley TP. Education and training of clinical and translational study investigators and research coordinators: A competency-based approach. J Clin Transl Sci. 2017 Feb; 1(1):16-25. PMID: 28480054.
      Citations:    
    21. Weiss ER, Alter G, Ogembo JG, Henderson JL, Tabak B, Bakis Y, Somasundaran M, Garber M, Selin L, Luzuriaga K. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. J Virol. 2017 Jan 01; 91(1). PMID: 27733645.
      Citations: 15     Fields:    Translation:HumansCells
    22. Luzuriaga K, Persaud D. Treatment interruption after early-treated perinatal HIV-1 infection. AIDS. 2016 09 24; 30(15):2381-3. PMID: 27603162.
      Citations:    Fields:    Translation:HumansCells
    23. Luzuriaga K, Mofenson LM. Eliminating Pediatric HIV-1 Infection. N Engl J Med. 2016 07 14; 375(2):193-4. PMID: 27410941.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    24. McManus M, Mick E, Hudson R, Mofenson LM, Sullivan JL, Somasundaran M, Luzuriaga K. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants. PLoS One. 2016; 11(4):e0154391. PMID: 27104621.
      Citations: 25     Fields:    Translation:HumansCells
    25. Luzuriaga K, Mofenson LM. Challenges in the Elimination of Pediatric HIV-1 Infection. N Engl J Med. 2016 Feb 25; 374(8):761-70. PMID: 26933850.
      Citations: 63     Fields:    Translation:HumansCellsPHPublic Health
    26. Luzuriaga K. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children. Annu Rev Med. 2016; 67:201-13. PMID: 26768239.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    27. Sanborn KB, Somasundaran M, Luzuriaga K, Leitner T. Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission. Retrovirology. 2015 Nov 16; 12:96. PMID: 26573574.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    28. Greenough TC, Straubhaar JR, Kamga L, Weiss ER, Brody RM, McManus MM, Lambrecht LK, Somasundaran M, Luzuriaga KF. A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol. 2015 Nov 01; 195(9):4185-97. PMID: 26416268.
      Citations: 16     Fields:    Translation:HumansCells
    29. Uprety P, Chadwick EG, Rainwater-Lovett K, Ziemniak C, Luzuriaga K, Capparelli EV, Yenokyan G, Persaud D. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants. Clin Infect Dis. 2015 Dec 15; 61(12):1862-70. PMID: 26270687.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    30. Klein N, Palma P, Luzuriaga K, Pahwa S, Nastouli E, Gibb DM, Rojo P, Borkowsky W, Bernardi S, Zangari P, Calvez V, Compagnucci A, Wahren B, Foster C, Munoz-Fern?ndez M?, De Rossi A, Ananworanich J, Pillay D, Giaquinto C, Rossi P. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. Lancet Infect Dis. 2015 Sep; 15(9):1108-1114. PMID: 26187030.
      Citations:    
    31. Palma P, Foster C, Rojo P, Zangari P, Yates A, Cotugno N, Klein N, Luzuriaga K, Pahwa S, Nastouli E, Gibb DM, Borkowsky W, Bernardi S, Calvez V, Manno E, Mora N, Compagnucci A, Wahren B, Mu?oz-Fern?ndez M, De Rossi A, Ananworanich J, Pillay D, Giaquinto C, Rossi P. The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children. J Virus Erad. 2015; 1(3):134-139. PMID: 26893908.
      Citations:    
    32. Gibson L, Barysauskas CM, McManus M, Dooley S, Lilleri D, Fisher D, Srivastava T, Diamond DJ, Luzuriaga K. Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol. 2015 Apr; 35(3):289-301. PMID: 25712611.
      Citations: 14     Fields:    Translation:HumansCells
    33. Luzuriaga K, Gay H, Ziemniak C, Sanborn KB, Somasundaran M, Rainwater-Lovett K, Mellors JW, Rosenbloom D, Persaud D. Viremic relapse after HIV-1 remission in a perinatally infected child. N Engl J Med. 2015 Feb 19; 372(8):786-8. PMID: 25693029.
      Citations: 161     Fields:    Translation:HumansCells
    34. Rainwater-Lovett K, Luzuriaga K, Persaud D. Very early combination antiretroviral therapy in infants: prospects for cure. Curr Opin HIV AIDS. 2015 Jan; 10(1):4-11. PMID: 25402708.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    35. Persaud D, Patel K, Karalius B, Rainwater-Lovett K, Ziemniak C, Ellis A, Chen YH, Richman D, Siberry GK, Van Dyke RB, Burchett S, Seage GR, Luzuriaga K. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. JAMA Pediatr. 2014 Dec; 168(12):1138-46. PMID: 25286283.
      Citations: 53     Fields:    Translation:HumansCellsPHPublic Health
    36. Luzuriaga K, Tabak B, Garber M, Chen YH, Ziemniak C, McManus MM, Murray D, Strain MC, Richman DD, Chun TW, Cunningham CK, Persaud D. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis. 2014 Nov 15; 210(10):1529-38. PMID: 24850788.
      Citations: 83     Fields:    Translation:HumansCellsPHPublic Health
    37. Persaud D, Luzuriaga K. Absence of HIV-1 after treatment cessation in an infant. N Engl J Med. 2014 02 13; 370(7):678. PMID: 24521123.
      Citations: 15     Fields:    Translation:HumansCells
    38. Renzette N, Somasundaran M, Brewster F, Coderre J, Weiss ER, McManus M, Greenough T, Tabak B, Garber M, Kowalik TF, Luzuriaga K. Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids. J Virol. 2014 Apr; 88(7):3744-55. PMID: 24429365.
      Citations: 11     Fields:    Translation:HumansCells
    39. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M, Chun TW, Strain M, Richman D, Luzuriaga K. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013 Nov 07; 369(19):1828-35. PMID: 24152233.
      Citations: 308     Fields:    Translation:HumansCells
    40. Wang S, Kishko M, Wan S, Wang Y, Brewster F, Gray GE, Violari A, Sullivan JL, Somasundaran M, Luzuriaga K, Lu S. Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates. Hum Vaccin Immunother. 2012 Nov 01; 8(11):1638-47. PMID: 23151449.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    41. Tracy SI, Kakalacheva K, L?nemann JD, Luzuriaga K, Middeldorp J, Thorley-Lawson DA. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol. 2012 Nov; 86(22):12330-40. PMID: 22951828.
      Citations: 41     Fields:    Translation:HumansCells
    42. Persaud D, Palumbo PE, Ziemniak C, Hughes MD, Alvero CG, Luzuriaga K, Yogev R, Capparelli EV, Chadwick EG. Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. AIDS. 2012 Jul 31; 26(12):1483-90. PMID: 22555165.
      Citations: 56     Fields:    Translation:HumansCells
    43. Persaud D, Luzuriaga K, Ziemniak C, Muresan P, Greenough T, Fenton T, Blackford A, Ferguson K, Neu N, Cunningham CK. Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir. AIDS. 2011 Nov 28; 25(18):2227-34. PMID: 21918423.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    44. Kishko M, Somasundaran M, Brewster F, Sullivan JL, Clapham PR, Luzuriaga K. Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology. 2011 Aug 15; 8:67. PMID: 21843318.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    45. Clute SC, Naumov YN, Watkin LB, Aslan N, Sullivan JL, Thorley-Lawson DA, Luzuriaga K, Welsh RM, Puzone R, Celada F, Selin LK. Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol. 2010 Dec 01; 185(11):6753-64. PMID: 21048112.
      Citations: 40     Fields:    Translation:HumansCells
    46. Greenough TC, Campellone SC, Brody R, Jain S, Sanchez-Merino V, Somasundaran M, Luzuriaga K. Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage. PLoS One. 2010 Sep 23; 5(9):e12926. PMID: 20886079.
      Citations: 15     Fields:    Translation:HumansCells
    47. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010 May 27; 362(21):1993-2000. PMID: 20505178.
      Citations: 178     Fields:    Translation:HumansCells
    48. Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K. Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination. Vaccine. 2010 May 07; 28(21):3672-8. PMID: 20356567.
      Citations: 14     Fields:    Translation:HumansCells
    49. Shiu C, Cunningham CK, Greenough T, Muresan P, Sanchez-Merino V, Carey V, Jackson JB, Ziemniak C, Fox L, Belzer M, Ray SC, Luzuriaga K, Persaud D. Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy. J Virol. 2009 Oct; 83(19):9731-42. PMID: 19605490.
      Citations: 31     Fields:    Translation:HumansCellsPHPublic Health
    50. Mehta N, Trzmielina S, Nonyane BA, Eliot MN, Lin R, Foulkes AS, McNeal K, Ammann A, Eulalievyolo V, Sullivan JL, Luzuriaga K, Somasundaran M. Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR. PLoS One. 2009 Jun 05; 4(6):e5819. PMID: 19503790.
      Citations: 16     Fields:    Translation:HumansCells
    51. Sanchez-Merino V, Farrow MA, Brewster F, Somasundaran M, Luzuriaga K. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness. J Infect Dis. 2008 Jan 15; 197(2):300-8. PMID: 18177249.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    52. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood. 2008 Feb 01; 111(3):1420-7. PMID: 17991806.
      Citations: 49     Fields:    Translation:Cells
    53. Luzuriaga K. Mother-to-child transmission of HIV: a global perspective. Curr Infect Dis Rep. 2007 Nov; 9(6):511-7. PMID: 17999887.
      Citations:    
    54. Duca KA, Shapiro M, Delgado-Eckert E, Hadinoto V, Jarrah AS, Laubenbacher R, Lee K, Luzuriaga K, Polys NF, Thorley-Lawson DA. A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog. 2007 Oct 19; 3(10):1388-400. PMID: 17953479.
      Citations: 14     Fields:    Translation:HumansCells
    55. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Influence of EBV on the peripheral blood memory B cell compartment. J Immunol. 2007 Sep 01; 179(5):3153-60. PMID: 17709530.
      Citations: 26     Fields:    Translation:HumansCells
    56. Luzuriaga K, Newell ML, Dabis F, Excler JL, Sullivan JL. Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities. Lancet. 2006 Aug 05; 368(9534):511-21. PMID: 16890838.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    57. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18093-8. PMID: 16330748.
      Citations: 55     Fields:    Translation:HumansCells
    58. Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, Luzuriaga K, Welsh RM, Selin LK. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest. 2005 Dec; 115(12):3602-12. PMID: 16308574.
      Citations: 99     Fields:    Translation:HumansCells
    59. Sanchez-Merino V, Nie S, Luzuriaga K. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants. J Immunol. 2005 Nov 15; 175(10):6976-86. PMID: 16272358.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    60. Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL. A trial of three antiretroviral regimens in HIV-1-infected children. N Engl J Med. 2004 Jun 10; 350(24):2471-80. PMID: 15190139.
      Citations: 46     Fields:    Translation:HumansCellsCTClinical Trials
    61. Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol. 2004 May; 78(10):5194-204. PMID: 15113901.
      Citations: 61     Fields:    Translation:HumansCells
    62. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A. 2004 Jan 06; 101(1):239-44. PMID: 14688409.
      Citations: 130     Fields:    Translation:HumansCells
    63. Luzuriaga K, Sullivan JL. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev. 2002 Jan-Mar; 4(1):21-6. PMID: 11998780.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    64. Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M, Sullivan JL. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol. 2000 Aug; 74(15):6984-91. PMID: 10888637.
      Citations: 64     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    Ruiz De Luzuriaga's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (251)
    Explore
    _
    Co-Authors (19)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _